# Simplify Propel Opportunities ETF

Simplify Propel Opportunities ETF is a ETF series of Simplify Exchange Traded Funds (series S000078061). Net assets $69.4M as of 2026-03-31.

## Profile

- Series ID: S000078061
- Registrant: Simplify Exchange Traded Funds
- LEI: 549300DJ9GVPZFC9VR09
- Net assets: $69.4M
- Total assets: $132.7M
- As of: 2026-03-31
- Type: ETF

## Advisers

- [Simplify Asset Management Inc. (Advisor)](https://search.stillhousedata.com/firm/309535)
- [Propel Bio Management, LLC (Subadvisor)](https://search.stillhousedata.com/firm/322858)

## Top holdings (48 reported)

_Showing 15 of 48 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [United States Treasury Bills](https://search.stillhousedata.com/security/912797TE7) | — | $64.5M | 9293.41% |
| [Plains GP Holdings LP](https://search.stillhousedata.com/security/72651A207) | — | $30.9M | 4454.62% |
| [Achieve Life Science Inc](https://search.stillhousedata.com/security/004468500) | — | $3.5M | 502.16% |
| [Phathom Pharmaceuticals Inc](https://search.stillhousedata.com/security/71722W107) | — | $2.9M | 420.35% |
| [Delcath Systems Inc.](https://search.stillhousedata.com/security/24661P807) | — | $2.4M | 349.42% |
| [Abeona Therapeutics Inc.](https://search.stillhousedata.com/security/00289Y206) | — | $2.2M | 323.22% |
| [Celldex Therapeutics Inc.](https://search.stillhousedata.com/security/15117B202) | — | $2.2M | 315.57% |
| [Milestone Pharmaceuticals Inc](https://search.stillhousedata.com/security/59935V107) | — | $1.8M | 258.49% |
| Oculis Holding AG | — | $1.8M | 255.61% |
| [LeonaBio Inc.](https://search.stillhousedata.com/security/04746L203) | — | $1.5M | 221.28% |
| [Corcept Therapeutics Inc.](https://search.stillhousedata.com/security/218352102) | — | $1.5M | 219.50% |
| [Kyverna Therapeutics Inc](https://search.stillhousedata.com/security/501976104) | — | $1.5M | 215.41% |
| [Inventiva SA](https://search.stillhousedata.com/security/46124U107) | — | $1.3M | 182.40% |
| [Viridian Therapeutics Inc](https://search.stillhousedata.com/security/92790C104) | — | $1.1M | 158.60% |
| [Aquestive Therapeutics Inc](https://search.stillhousedata.com/security/03843E104) | — | $972K | 140.20% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-03-31 | $69.4M |
| 2025-12-31 | $75.2M |
| 2025-09-30 | $69.1M |
| 2025-06-30 | $65.0M |
| 2025-03-31 | $68.8M |
| 2024-12-31 | $71.4M |
| 2024-09-30 | $104.2M |
| 2024-06-28 | $96.9M |

## More

- [Registrant: Simplify Exchange Traded Funds](https://search.stillhousedata.com/registrant/1810747)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000078061.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.